ContextAlthough amiodarone is approved by the US Food and Drug Administration only for
refractory ventricular arrhythmias, it is one of the most frequently prescribed antiarrhythmic …

placebo-controlled studies. Nonetheless, amiodarone is approved for use against VT and
VF by most regulatory agencies worldwide and has a high profile as a useful drug. 21 Its …

Purpose: To assess the incidence of amiodarone-mediated aggravation of ventricular
tachyarrhythmias or the development of new arrhythmias, such as torsade de pointes, in …

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Purpose: To review the pharmacology, electrophysiology, and toxicity of amiodarone and to
discuss the clinical results produced when amiodarone is used as therapy for patients with …

Amiodarone (Am) is an antiarrhythmic benzofuran drug with an imposing adverse effect
profile, that involves the liver, thyroid, cornea, skin, and neuromuscular system, which often …

Four hundred sixty-two patients, all with either documented spontaneous sustained
ventricular tachycardia or cardiac arrest unresponsive to other antiarrhythmic drugs …

Rationale: Although there have been reports of pulmonary toxicity with low-dose
amiodarone, it is generally believed that low-dose therapy is safe. Methods: The clinical data …

Objectives. The goal of this study was to evaluate the effect of amiodarone on mortality,
ventricular arrhythmias and clinical complications in high risk postinfarction patients …

Acute Eosinophilic Pneumonia Alveolar Hemorrhage Syndromes Systemic Lupus
Erythematosus Wegener's Granulomatosis Microscopic Polyangiitis Anti–Glomerular …